Related references
Note: Only part of the references are listed.Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
Stefanie Desmet et al.
LANCET INFECTIOUS DISEASES (2021)
Application of a Pneumococcal Serotype-specific Urinary Antigen Detection Test for Identification of Pediatric Pneumonia in Burkina Faso
Mamadou Bountogo et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2021)
New Pneumococcal Serotype 15D
Fabiana Pimenta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project
Maria Garcia Quesada et al.
MICROORGANISMS (2021)
Efficacy and Effectiveness of the PCV-10 and PCV-13 Vaccines Against Invasive Pneumococcal Disease
Melissa Berman-Rosa et al.
PEDIATRICS (2020)
Sugar-Coated Killer: Serotype 3 Pneumococcal Disease
Jennifer N. Luck et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults
Allison Thompson et al.
VACCINE (2019)
Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader
Natalie Groves et al.
GENES (2019)
Burden of Streptococcus pneumoniae Sepsis in Children After Introduction of Pneumococcal Conjugate Vaccines: A Prospective Population-based Cohort Study
Sandra A. Asner et al.
CLINICAL INFECTIOUS DISEASES (2019)
Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies
Heather L. Sings et al.
CLINICAL INFECTIOUS DISEASES (2019)
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
Helen L. Stacey et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15
Brian Wahl et al.
LANCET GLOBAL HEALTH (2018)
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
David Greenberg et al.
VACCINE (2018)
Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7-and 13-Valent Vaccines, Israel
Assaf Rokney et al.
EMERGING INFECTIOUS DISEASES (2018)
Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries
Robert Cohen et al.
EXPERT REVIEW OF VACCINES (2017)
Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine
Joon Kee Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis
Evelyn Balsells et al.
PLOS ONE (2017)
Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014
Godwin Oligbu et al.
CLINICAL INFECTIOUS DISEASES (2017)
Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine
Sara Tomczyk et al.
CLINICAL INFECTIOUS DISEASES (2016)
Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA
B. J. Metcalf et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement
William P. Hausdorff et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study
Matthew R. Moore et al.
LANCET RESPIRATORY MEDICINE (2016)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study
Pauline A. Waight et al.
LANCET INFECTIOUS DISEASES (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Outbreak of Invasive Streptococcus pneumoniae Serotype 12F Among a Marginalized Inner-City Population in Winnipeg, Canada, 2009-2011
Erin Schillberg et al.
CLINICAL INFECTIOUS DISEASES (2014)
Pneumococcal infection in adults: burden of disease
J. J. C. Drijkoningen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use
Jonathan F. Mosser et al.
PLOS ONE (2014)
Comparative Immunogenicity and Efficacy of 13-Valent and 7-Valent Pneumococcal Conjugate Vaccines in Reducing Nasopharyngeal Colonization: A Randomized Double-Blind Trial
Ron Dagan et al.
CLINICAL INFECTIOUS DISEASES (2013)
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Anneke Steens et al.
VACCINE (2013)
Effect of Serotype on Focus and Mortality of Invasive Pneumococcal Disease: Coverage of Different Vaccines and Insight into Non-Vaccine Serotypes
Albert Jan van Hoek et al.
PLOS ONE (2012)
Invasive pneumococcal disease
Elise Randle et al.
ARCHIVES OF DISEASE IN CHILDHOOD-EDUCATION AND PRACTICE EDITION (2011)
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers
Sylvia H. Yeh et al.
PEDIATRICS (2010)
Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children
WP Hausdorff et al.
LANCET (2001)
Share Paper
